摘要:
The present invention provides methods useful for predicting the likelihood that a mammal that will respond therapeutically to a method of treating cancer comprising administering an EGFR modulator, and diagnostic methods and kits thereof.
摘要:
Method, device and system of obtaining the network information using the device as the service credential, which use the device without power supply and display, in which presetting the configuration files containing the information connected to the network, after connecting the device with the online data process device, establishing the information interacting channel between the data process device and the information server to obtain, download the related information. The device as the service credential can be used to store the information, or display, print and output the special network service information by the data process device, and the device can be used as the service object of the special information network and take the voucher function of service.
摘要:
Method, device and system of obtaining the network information using the device as the service credential, which use the device without power supply and display, in which presetting the configuration files containing the information connected to the network, after connecting the device with the online data process device, establishing the information interacting channel between the data process device and the information server to obtain, download the related information. The device as the service credential can be used to store the information, or display, print and output the special network service information by the data process device, and the device can be used as the service object of the special information network and take the voucher function of service.
摘要:
The present invention relates to biomarker polypeptides, polynucleotides, and antibodies that have utility in predicting in vitro and/or in vivo hepatotoxicity of various drugs, compounds, or other therapeutic agents (i.e., test substances). Also related are screens, kits, microarrays, and cell culture systems that employ the polypeptides, polynucleotides, and/or antibodies of the invention. The reagents and methods of the invention are useful for predicting hepatotoxic effects resulting from treatment with one or more test substances, and can be utilized before, after, or concurrently with pre-clinical, clinical, and/or post-clinical testing. In this way, the reagents and methods of the invention can be used to identify test substances or combinations of test substances that cause hepatic injury, including idiosyncratic hepatotoxicity, and thereby prevent medical complications (e.g., liver failure) resulting from such injury.